Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of histone deacetylase 8 (HDAC8). Also described herein are methods of using such HDAC8 inhibitors, alone and in combination with other compounds, for treating diseases or conditions that benefit from inhibition of HDAC8 activity
本文描述了含有这些化合物的药物组合物,这些化合物抑制组蛋白
去乙酰化酶8(H
DAC8)的活性。本文还描述了使用这种H
DAC8
抑制剂的方法,单独或与其他化合物联合使用,用于治疗受益于抑制H
DAC8活性的疾病或状况。